Alimentary Pharmacology and Therapeutics, 50(4), 407-415 Kreijne, J E, de Veer, R C, de Boer, N K, Dijkstra, G, West, R, Moorsel, S A W, de Jong, D J, van der Woude, C J, de Vries, A C & of the Dutch Initiative on Crohn, Colitis (ICC) 2019, ' Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment ', Alimentary Pharmacology and Therapeutics, vol. 50, no. 4, pp. 407-415 . https://doi.org/10.1111/apt.15402 Alimentary Pharmacology & Therapeutics, 50, 4, pp. 407-415 Alimentary Pharmacology & Therapeutics, 50, 407-415 Alimentary Pharmacology & Therapeutics, 50(4), 407-415. Wiley-Blackwell Publishing Ltd Alimentary Pharmacology & Therapeutics, 50(4), 407-415. Wiley
Kreijne, J E, de Vries, A C, de Veer, R C, Bouma, G, Dijkstra, G, Voskuil, M D, West, R, van Moorsel, S A W, de Jong, D J, de Boer, N K, van der Woude, C J & the initiative on Crohn and Colitis (ICC) 2020, ' Limited added value of laboratory monitoring in thiopurine maintenance monotherapy in inflammatory bowel disease patients ', Alimentary Pharmacology and Therapeutics, vol. 51, no. 12, pp. 1353-1364 . https://doi.org/10.1111/apt.15734 Alimentary Pharmacology & Therapeutics, 51(12), 1353-1364. Wiley-Blackwell Publishing Ltd Alimentary Pharmacology & Therapeutics, 51, 12, pp. 1353-1364 Alimentary Pharmacology and Therapeutics, 51(12), 1353-1364 Alimentary Pharmacology & Therapeutics, 51(12), 1353-1364. Wiley Alimentary Pharmacology & Therapeutics, 51, 1353-1364